41 filings
8-K
BEAM
Beam Therapeutics Inc
27 Feb 24
Beam Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Reiterates Anticipated Milestones
6:43am
8-K
BEAM
Beam Therapeutics Inc
8 Jan 24
Results of Operations and Financial Condition
6:55am
8-K
BEAM
Beam Therapeutics Inc
14 Dec 23
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors
4:05pm
8-K
BEAM
Beam Therapeutics Inc
8 Nov 23
Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results
7:00am
8-K
BEAM
Beam Therapeutics Inc
31 Oct 23
Beam Announces Agreement for Lilly to Acquire Beam’s Opt-In Rights to Verve Therapeutics’ Base Editing Programs for Cardiovascular Disease
6:44am
8-K
giaqy0eit zb
19 Oct 23
Cost Associated with Exit or Disposal Activities
8:50am
8-K
vhjznq6i7uldjnveqdsm
8 Aug 23
Beam Therapeutics Reports Pipeline Updates and Second Quarter 2023 Financial Results
7:11am
8-K
4w27avyz 78
8 Jun 23
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
ng5x4y
10 May 23
Entry into a Material Definitive Agreement
4:56pm
8-K
2302zx p7ulg
10 May 23
Beam Therapeutics Reports Pipeline Updates and First Quarter 2023 Financial Results
7:00am
8-K
ryflefe
28 Feb 23
Beam Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones
7:01am
8-K
8fgtn vvbsff
9 Jan 23
Results of Operations and Financial Condition
7:09am
8-K
w5e6j1efkb 7pci9bi5
7 Nov 22
Beam Therapeutics Announces Portfolio Progress and Reports Third Quarter 2022 Financial Results
7:00am
8-K
rczzk 4uzmy
7 Sep 22
Other Events
6:47am
8-K
jo4a3op
30 Aug 22
Other Events
7:08am
8-K
re93oxk
9 Aug 22
Beam Therapeutics Announces Pipeline and Business Highlights and Reports Second Quarter 2022 Financial Results
7:00am
8-K
7ywmlrduyvsj
1 Aug 22
Beam Therapeutics Announces FDA Clinical Hold on BEAM-201 IND Application
6:50am
8-K
y6lxc
10 Jun 22
Submission of Matters to a Vote of Security Holders
4:57pm
8-K
zwy nlsysfw2fvr18
9 May 22
Beam Therapeutics Announces Pipeline and Business Highlights and Reports First Quarter 2022 Financial Results
7:01am
8-K
2efwn77
28 Feb 22
Beam Therapeutics Reports Pipeline and Business Highlights, Planned 2022 Milestones and Fourth Quarter and Full Year 2021 Financial Results
7:00am